Key statistics
On Friday, Novocure Ltd (NVCR:NSQ) closed at 17.44, 60.44% above the 52 week low of 10.87 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.65 |
---|---|
High | 18.67 |
Low | 17.28 |
Bid | 17.33 |
Offer | 17.57 |
Previous close | 17.65 |
Average volume | 1.07m |
---|---|
Shares outstanding | 108.20m |
Free float | 98.19m |
P/E (TTM) | -- |
Market cap | 1.89bn USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Novocure Appoints Christoph Brackmann as Chief Financial Officer
- Novocure Reports Third Quarter 2024 Financial Results
- Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
- FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
- Novocure to Report Third Quarter 2024 Financial Results
- Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
- Novocure Announces Planned CEO Transition
- Novocure to Participate in 2024 Wells Fargo Healthcare Conference
- Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
More ▼